reviewTime

5 triples
GPTKB property

Random triples
Subject Object
gptkb:510(k)_premarket_notification_for_medical_devices typically 90 days
gptkb:Priority_Review_designation 6 months
gptkb:510(k)_clearance_in_US typically 90 days
gptkb:New_Drug_Applications_(NDA) 6 months priority review
gptkb:New_Drug_Applications_(NDA) typically 10 months standard review